14-6-4　ⓔ文献

  1. 厚生労働科学研究費補助金 疾病・障害対策研究分野 難治性疾患等政策研究 (難治性疾患政策研究)，アミロイドーシスに関する調査研究班：アミロイドーシス診療ガイドライン 2017．

  2. 難病情報センターホームページ．www.nanbyou.or.jp

  3. Wechalekar AD, Gillmore JD, et al: Systemic amyloidosis. Lancet, 2016; 387: 2641–2654.

  4. Sugiyama H, Yokoyama H, et al: Japan Renal Biopsy Registry: the first nationwide, web–based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol, 2011; 15: 493–503.

  5. Nishi S, Muso E, et al: A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross–sectional study. Clin Exp Nephrol, 2017; 21: 624–632.

  6. Yokoyama H, Sugiyama H, et al: Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J–RBR). Clin Exp Nephrol, 2012; 16: 903–920.

  7. Shiiki H, Shimokama T, et al: Renal amyloidosis. Correlations between morphology, chemical types of amyloid protein and clinical features. Virchows Arch A Pathol Anat Histopathol, 1988; 412: 197–204.

  8. Palladini G, Russo P, et al: Identification of amyloidogenic light chains requires the combination of serum–free light chainassay with immunofixation of serum and urine. Clin Chem, 2009; 55: 499–504.

  9. 日本血液学会編：造血器腫瘍診療ガイドライン2018年版 補訂版．http://www.jshem.or.jp/gui-hemail/table.html